Michael W. Dunne

CIK 1553593 · Chief Scientific Officer · last filed 2025-11-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

36

Lifetime Open-Market Net

$113.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Iterum Therapeutics plc (ITRM) Delisted Director 241,001 $0.03 $7.2K $113.0K 30 2025-11-20
AVIR Director $4.49 $0 2 2017-05-22
Vaxart, Inc. (BOTA) Delisted Director $0 1 2015-10-21
Durata Therapeutics, Inc. (DRTX) Delisted Chief Medical Officer 0 $0 3 2014-11-18

Recent Filings · Page 4 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-05-22 AVIR Grant (A) $0 EDGAR
2016-05-13 AVIR Grant (A) $0 EDGAR
2015-10-21 Vaxart, Inc. (BOTA) Delisted Grant (A) $0 EDGAR
2014-11-18 Durata Therapeutics, Inc. (DRTX) Delisted Disp (D) −13,220 $0 EDGAR
2013-02-14 Durata Therapeutics, Inc. (DRTX) Delisted Grant (A) $0 EDGAR
2012-07-26 Durata Therapeutics, Inc. (DRTX) Delisted Mixed +11,220 $0 EDGAR
Showing 3136 of 36
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.